These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29121713)

  • 1. Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study.
    Kang D; Cho J; Kim IR; Kim MK; Kim WS; Kim SJ
    Cancer Res Treat; 2018 Oct; 50(4):1051-1063. PubMed ID: 29121713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic literature review of health-related quality of life among aggressive non-Hodgkin lymphoma survivors.
    Lin VW; Blaylock B; Epstein J; Purdum A
    Curr Med Res Opin; 2018 Aug; 34(8):1529-1535. PubMed ID: 29741105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.
    Busson R; van der Kaaij M; Mounier N; Aleman BMP; Thiéblemont C; Stamatoullas A; Ribrag V; Tilly H; Haioun C; Casasnovas RO; Kluin-Nelemans HC; Henry-Amar M
    Health Qual Life Outcomes; 2019 Jul; 17(1):115. PubMed ID: 31266501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unmet needs of non-Hodgkin lymphoma survivors in Korea: prevalence, correlates, and associations with health-related quality of life.
    Kim SH; Lee S; Kim SH; Ok ON; Kim IR; Choi E; Kang YK; Kim SJ; Lee MH
    Psychooncology; 2017 Mar; 26(3):330-336. PubMed ID: 27073128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
    Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV;
    Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of fear of cancer recurrence on survival among lymphoma patients.
    Kim SJ; Kang D; Kim IR; Yoon SE; Kim WS; Butow PN; Guallar E; Cho J
    Psychooncology; 2020 Feb; 29(2):364-372. PubMed ID: 31654534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life appears similar between survivors of indolent and aggressive non-Hodgkin lymphoma.
    Blaes AH; Ma L; Zhang Y; Peterson BA
    Leuk Lymphoma; 2011 Nov; 52(11):2105-10. PubMed ID: 21740095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive, psychosocial, and quality-of-life outcomes in adult survivors of childhood non-Hodgkin lymphoma.
    Ehrhardt MJ; Mulrooney DA; Li C; Baassiri MJ; Bjornard K; Sandlund JT; Brinkman TM; Huang IC; Srivastava DK; Ness KK; Robison LL; Hudson MM; Krull KR
    Cancer; 2018 Jan; 124(2):417-425. PubMed ID: 28915338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and related demographic factors in long-term survivors of childhood non-Hodgkin's lymphoma.
    Hu Y; Wu LH; Guan HJ; Wu SY; Liu LZ; Cai RQ; Xu YJ; Zhang YZ; Sun XF; Zhu J
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Sept 15; 23(9):882-888. PubMed ID: 34535201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort.
    Anota A; Basset M; Charton E; Bommier C; Efficace F; Dupuis J; Cottone F; Bouabdallah KK; Mollevi C; Ysebaert L; Winter A; Bijou F; Préau M; Chauchet A; Bernier A; Fornecker LM; Hafirassou H; Carras S; Lachenal F; Lionne-Huyghe P; Detourmignies L; Leyronnas C; Drénou B; Peyrou SLG; Abraham J; Monnereau A; Fouillet L; Morschhauser F; Rossi C; Belot A; Ghesquières H
    Eur J Cancer; 2024 Sep; 208():114210. PubMed ID: 39002346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey.
    Compaci G; Conte C; Oberic L; Ysebaert L; Laurent G; Despas F
    BMC Cancer; 2019 Dec; 19(1):1178. PubMed ID: 31795958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of Life is Similar between Long-term Survivors of Indolent and Aggressive Non-Hodgkin Lymphoma.
    Beaven AW; Samsa G; Zimmerman S; Smith SK
    Cancer Invest; 2016 Jul; 34(6):279-85. PubMed ID: 27379565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
    Vachon H; Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Fortpied C; Flechtner HH; Vestmoe Maraldo M; Hutchings M; Meijnders P; Aleman B; Lugtenburg P; Spina M; André M; Hertzberg M; Briones J; Bottomley A;
    Eur J Haematol; 2021 May; 106(5):697-707. PubMed ID: 33570765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
    van de Poll-Franse L; Oerlemans S; Bredart A; Kyriakou C; Sztankay M; Pallua S; Daniëls L; Creutzberg CL; Cocks K; Malak S; Caocci G; Molica S; Chie W; Efficace F;
    Qual Life Res; 2018 Feb; 27(2):333-345. PubMed ID: 29127596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Korean Version of the Quality of Life-Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors.
    Cho J; Kang D; Kim IR; Kim WS; Ferrell B; Kim SJ
    Cancer Res Treat; 2018 Jan; 50(1):204-211. PubMed ID: 28361524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute, long-term or non-vincristine-induced peripheral neuropathy among non-Hodgkin lymphoma survivors: Symptoms, daily activities, functional status, and quality of life.
    Su YC; Lai YH; Hsieh ST; Teng CJ; Lee YH
    Eur J Oncol Nurs; 2024 Apr; 69():102540. PubMed ID: 38461728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study.
    Paunescu AC; Copie CB; Malak S; Gouill SL; Ribrag V; Bouabdallah K; Sibon D; Rumpold G; Preau M; Mounier N; Haioun C; Jardin F; Besson C
    Ann Hematol; 2022 Feb; 101(2):317-332. PubMed ID: 34617134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry.
    Vissers PA; Thong MS; Pouwer F; Zanders MM; Coebergh JW; van de Poll-Franse LV
    J Cancer Surviv; 2013 Dec; 7(4):602-13. PubMed ID: 23918453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life among survivors of aggressive non-Hodgkin lymphoma.
    Jensen RE; Arora NK; Bellizzi KM; Rowland JH; Hamilton AS; Aziz NM; Potosky AL
    Cancer; 2013 Feb; 119(3):672-80. PubMed ID: 22951588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin's and non-Hodgkin's lymphoma survivors: a systematic review.
    Oerlemans S; Mols F; Nijziel MR; Lybeert M; van de Poll-Franse LV
    Ann Hematol; 2011 Sep; 90(9):993-1004. PubMed ID: 21670973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.